A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants
Eligible age
18–75 yrs
Accepts
All genders
Locations
31 states
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
This study will evaluate the efficacy and safety of Armour Thyroid treatment compared with synthetic T4 in subjects who have primary hypothyroidism and are currently stabilized (i.e., in-range thyroid-stimulating hormone \[TSH\]) on synthetic T4 treatment. This study will also therefore evaluate the efficacy and safety of dose conversion from synthetic T4 therapy to Armour Thyroid therapy.
Sponsor: AbbVie
You may qualify if…
- ✓ Have a diagnosis of primary hypothyroidism made \>= 12 months prior to Screening.
- ✓ Be on continuous thyroid replacement therapy of synthetic T4 for primary hypothyroidism for at least 12 months immediately prior to the Screening Visit.
- ✓ Be on a stable FDA-approved daily dose of synthetic T4 prior to the Screening visit, and must be taking synthetic T4 dose of at least 25 mcg at Screening visit. Must enter the study using the same stable dose to determine dose conversion.
- ✓ Documentation of 1 in-range thyroid-stimulating hormone (TSH) (i.e., within 0.45 - 4.12 mIU/L, inclusive) at Screening and at least 1 additional in range TSH (i.e., within 0.45 - 4.12 mIU/L, inclusive) taken at a minimum of 6 weeks and a maximum of 12 months prior to Screening.
You may not qualify if…
- ✕ Any clinical condition or previous surgery that might affect the absorption, distribution, biotransformation, or excretion of Armour Thyroid or synthetic T4.
- ✕ History of alcohol or other substance abuse within the previous 6 months prior to the Screening.
- ✕ Known or suspected allergy or intolerance to any ingredients of Armour Thyroid, including its excipients, synthetic T4, other thyroid replacement medications, or pork products.
Where it's recruiting
Birmingham
Bonita · Burbank · Concord · Encinitas …
Bridgeport
Clearwater · Cooper City · Fleming Island · Fort Lauderdale …
Atlanta · Canton · Columbus · Lawrenceville …
Honolulu
Idaho Falls
Chicago
Council Bluffs · West Des Moines
Topeka
Louisville
Baton Rouge · Metairie
Source: ClinicalTrials.gov · NCT06345339 · last updated 2026-01-05